MD-18

DRUG2 trials

Sponsors

Cohen Global, Ltd.

Conditions

Healthy VolunteerHealthy Volunteers

Phase 1

Subcutaneous Administration of MD-18 in Healthy Subjects

Active, not recruitingNCT06259903

Cohen Global, Ltd.Healthy Volunteers

Start: 2024-05-07End: 2025-04-30Target: 35Updated: 2024-10-01

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

SuspendedNCT06739707

Cohen Global, Ltd.Healthy Volunteer

Start: 2025-01-02End: 2026-12-01Target: 54Updated: 2026-05-20